Healthequity Inc’s recently made public that its EVP, General Counsel Ladd Delano unloaded Company’s shares for reported $0.56 million on Sep 19 ’25. In the deal valued at $94.11 per share,6,000 shares were sold. As a result of this transaction, Ladd Delano now holds 79,456 shares worth roughly $7.63 million.
Then, DELANO LADD bought 9,000 shares, generating $860,310 in total proceeds.
Before that, Dilsaver Evelyn S sold 3,461 shares. Healthequity Inc shares valued at $322,916 were divested by the Director at a price of $93.30 per share. As a result of the transaction, Dilsaver Evelyn S now holds 48,208 shares, worth roughly $4.63 million.
A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in late March from “an Outperform” to “a Strong buy”. Mizuho began covering HQY with “an Outperform” recommendation on December 04, 2024. Goldman started covering the stock on November 15, 2024. It rated HQY as “a Neutral”.
Price Performance Review of HQY
On Monday, Healthequity Inc [NASDAQ:HQY] saw its stock jump 2.38% to $95.97. Over the last five days, the stock has gained 3.17%. Healthequity Inc shares have risen nearly 23.77% since the year began. Nevertheless, the stocks have risen 0.02% over the past one year. While a 52-week high of $116.65 was reached on 06/05/25, a 52-week low of $74.07 was recorded on 04/07/25.
Levels Of Support And Resistance For HQY Stock
The 24-hour chart illustrates a support level at 93.99, which if violated will result in even more drops to 92.02. On the upside, there is a resistance level at 97.00. A further resistance level may holdings at 98.04.
How much short interest is there in Healthequity Inc?
A steep rise in short interest was recorded in Healthequity Inc stocks on 2025-08-29, growing by 0.21 million shares to a total of 5.01 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 4.8 million shares. There was a rise of 4.24%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 04, 2024 when JMP Securities began covering the stock and recommended ‘”a Mkt outperform”‘ rating along with a $101 price target.
